Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 3/2023

29-05-2023 | Mifepristone | Conference Abstracts

ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023

Published in: International Journal of Clinical Pharmacy | Issue 3/2023

Login to get access

Excerpt

Background and Objective: Antithrombotic therapy prescribing after percutaneous coronary intervention (PCI) is challenging and requires consideration of bleeding and ischaemic risk. The aims were to assess bleeding risk, optimise antithrombotic therapy prescribing and evaluate outcomes in patients undergoing PCI. …
Metadata
Title
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023
Publication date
29-05-2023
Publisher
Springer International Publishing
Keyword
Mifepristone
Published in
International Journal of Clinical Pharmacy / Issue 3/2023
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-023-01599-5

Other articles of this Issue 3/2023

International Journal of Clinical Pharmacy 3/2023 Go to the issue

Research Article

Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences

Review Article

Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review

Research Article

Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies

Research Article

Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study

Research Article

Development and evaluation of pharmacist-provided teach-back medication counselling at hospital discharge

Research Article

Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits